Switch theme
Sign up to access all valuation multiples
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.
2014
10.7K+
LTM Revenue $1.0B
LTM EBITDA $103M
$1.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Enhabit has a last 12-month revenue (LTM) of $1.0B and a last 12-month EBITDA of $103M.
In the most recent fiscal year, Enhabit achieved revenue of $1.0B and an EBITDA of -$83.6M.
Enhabit expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Enhabit valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.0B | XXX | $1.0B | XXX | XXX | XXX |
| Gross Profit | $511M | XXX | $504M | XXX | XXX | XXX |
| Gross Margin | 49% | XXX | 49% | XXX | XXX | XXX |
| EBITDA | $103M | XXX | -$83.6M | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | -8% | XXX | XXX | XXX |
| EBIT | $71.4M | XXX | $46.6M | XXX | XXX | XXX |
| EBIT Margin | 7% | XXX | 5% | XXX | XXX | XXX |
| Net Profit | -$76.3M | XXX | -$156M | XXX | XXX | XXX |
| Net Margin | -7% | XXX | -15% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $487M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Enhabit's stock price is $10.
Enhabit has current market cap of $532M, and EV of $1.0B.
See Enhabit trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.0B | $532M | XXX | XXX | XXX | XXX | $0.33 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Enhabit has market cap of $532M and EV of $1.0B.
Enhabit's trades at 1.0x EV/Revenue multiple, and -12.4x EV/EBITDA.
Equity research analysts estimate Enhabit's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Enhabit has a P/E ratio of -7.0x.
See valuation multiples for Enhabit and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $532M | XXX | $532M | XXX | XXX | XXX |
| EV (current) | $1.0B | XXX | $1.0B | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | 10.1x | XXX | -12.4x | XXX | XXX | XXX |
| EV/EBIT | 14.5x | XXX | 22.2x | XXX | XXX | XXX |
| EV/Gross Profit | 2.0x | XXX | n/a | XXX | XXX | XXX |
| P/E | -7.0x | XXX | -3.4x | XXX | XXX | XXX |
| EV/FCF | 18.5x | XXX | 21.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialEnhabit's last 12 month revenue growth is 4%
Enhabit's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $43K for the same period.
Enhabit's rule of 40 is 2% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Enhabit's rule of X is 19% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Enhabit and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | -8% | XXX | XXX | XXX |
| EBITDA Growth | 6% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | 2% | XXX | -4% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 19% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $43K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 44% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| National Healthcare Corp | XXX | XXX | XXX | XXX | XXX | XXX |
| Regis Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Maternus-Kliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| Addus HomeCare | XXX | XXX | XXX | XXX | XXX | XXX |
| Amedisys | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Enhabit acquired XXX companies to date.
Last acquisition by Enhabit was XXXXXXXX, XXXXX XXXXX XXXXXX . Enhabit acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Enhabit founded? | Enhabit was founded in 2014. |
| Where is Enhabit headquartered? | Enhabit is headquartered in United States of America. |
| How many employees does Enhabit have? | As of today, Enhabit has 10.7K+ employees. |
| Who is the CEO of Enhabit? | Enhabit's CEO is Ms. Barbara A. Jacobsmeyer. |
| Is Enhabit publicy listed? | Yes, Enhabit is a public company listed on NYS. |
| What is the stock symbol of Enhabit? | Enhabit trades under EHAB ticker. |
| When did Enhabit go public? | Enhabit went public in 2022. |
| Who are competitors of Enhabit? | Similar companies to Enhabit include e.g. National Healthcare Corp, Regis Healthcare, Maternus-Kliniken, Addus HomeCare. |
| What is the current market cap of Enhabit? | Enhabit's current market cap is $532M |
| What is the current revenue of Enhabit? | Enhabit's last 12 months revenue is $1.0B. |
| What is the current revenue growth of Enhabit? | Enhabit revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of Enhabit? | Current revenue multiple of Enhabit is 1.0x. |
| Is Enhabit profitable? | Yes, Enhabit is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Enhabit? | Enhabit's last 12 months EBITDA is $103M. |
| What is Enhabit's EBITDA margin? | Enhabit's last 12 months EBITDA margin is 10%. |
| What is the current EV/EBITDA multiple of Enhabit? | Current EBITDA multiple of Enhabit is 10.1x. |
| What is the current FCF of Enhabit? | Enhabit's last 12 months FCF is $56.0M. |
| What is Enhabit's FCF margin? | Enhabit's last 12 months FCF margin is 5%. |
| What is the current EV/FCF multiple of Enhabit? | Current FCF multiple of Enhabit is 18.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
